Treatment of preclinical medullary thyroid carcinoma in MEN 2A gene carrier
- 15 October 1994
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 344 (8929) , 1084-1085
- https://doi.org/10.1016/s0140-6736(94)91739-6
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Identification of the Cys634->Tyr mutation of the RET proto-oncogene in a pedigree with multiple endocrine neoplasia type 2A and localized cutaneous lichen amyloidosisJournal of Endocrinological Investigation, 1994
- A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinomaNature, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993
- Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2ANature, 1993
- Pathology of Multiple Endocrine Neoplasias 2A and 2B: A ReviewHormone Research, 1992